scholarly journals Time-restricted feeding improves insulin resistance and hepatic steatosis in a mouse model of postmenopausal obesity

Metabolism ◽  
2016 ◽  
Vol 65 (12) ◽  
pp. 1743-1754 ◽  
Author(s):  
Heekyung Chung ◽  
Winjet Chou ◽  
Dorothy D. Sears ◽  
Ruth E. Patterson ◽  
Nicholas J.G. Webster ◽  
...  
2006 ◽  
Vol 281 (49) ◽  
pp. 37603-37615 ◽  
Author(s):  
Yuan-Li Zhang ◽  
Antonio Hernandez-Ono ◽  
Patty Siri ◽  
Stuart Weisberg ◽  
Donna Conlon ◽  
...  

2018 ◽  
Vol 32 (S1) ◽  
Author(s):  
Manasi Das ◽  
Emilie Gross ◽  
Deepak Kumar ◽  
Consuelo Sauceda ◽  
Hyun‐Tae Park ◽  
...  

2019 ◽  
Vol 3 (Supplement_1) ◽  
Author(s):  
Manasi Das ◽  
Deepak Kumar ◽  
Consuelo Sauceda ◽  
Emilie Gross ◽  
Hyun-Tae Park ◽  
...  

Nutrients ◽  
2021 ◽  
Vol 13 (10) ◽  
pp. 3579
Author(s):  
Francesc Ribas-Aulinas ◽  
Marcela Parra-Vargas ◽  
Marta Ramon-Krauel ◽  
Ruben Diaz ◽  
Carles Lerin ◽  
...  

Background: Time restricted feeding (TRF) refers to dietary interventions in which food access is limited during a specific timeframe of the day. TRFs have proven useful in improving metabolic health in adult subjects with obesity. Their beneficial effects are mediated, in part, through modulating the circadian rhythm. Nevertheless, the translation of these dietary interventions onto obese/overweight children and adolescents remains uncharacterized. The objective of this study is to explore the feasibility of temporal dietary interventions for improving metabolic health in the context of childhood obesity. Methods: We have previously developed a mouse model of early adiposity (i.e., childhood obesity) through litter size reduction. Mice raised in small litters (SL) became obese as early as by two weeks of age, and as adults, they developed several obesity-related co-morbidities, including insulin resistance, glucose intolerance and hepatic steatosis. Here, we explored whether two independent short-term chrono-nutritional interventions might improve metabolic health in 1-month-old pre-pubertal SL mice. Both TRFs comprised 8 h feeding/14 h fasting. In the first one (TRF1) Control and SL mice had access to the diet for 8 h during the dark phase. In the second intervention (TRF2) food was available during the light:dark transitions. Results: TRF1 did not alter food intake nor ameliorate adiposity in SL-TRF1. In contrast, SL-TRF2 mice showed unintentional reduction of caloric intake, which was accompanied by reduced total body weight and adiposity. Strikingly, hepatic triglyceride content was completely normalized in SL-TRF1 and SL-TRF2 mice, when compared to the ad lib-fed SL mice. These effects were partially mediated by (i) clock-dependent signals, which might modulate the expression of Pparg or Cpt1a, and (ii) clock-independent signals, such as fasting itself, which could influence Fasn expression. Conclusions: Time-restricted feeding is an effective and feasible nutritional intervention to improve metabolic health, namely hepatic steatosis, in a model of childhood obesity. These data open new avenues for future safe and efficient chrono-nutritional interventions aimed to improve metabolic health in children with overweight/obesity.


Life Sciences ◽  
2021 ◽  
Vol 264 ◽  
pp. 118618 ◽  
Author(s):  
Claudia Sardi ◽  
Elisa Martini ◽  
Tommaso Mello ◽  
Simone Camelliti ◽  
Lucia Sfondrini ◽  
...  

2009 ◽  
Vol 9 (2) ◽  
pp. 165-176 ◽  
Author(s):  
Víctor A. Cortés ◽  
David E. Curtis ◽  
Suja Sukumaran ◽  
Xinli Shao ◽  
Vinay Parameswara ◽  
...  

2021 ◽  
Vol 17 (1) ◽  
Author(s):  
Frode Norheim ◽  
Karthickeyan Chella Krishnan ◽  
Thomas Bjellaas ◽  
Laurent Vergnes ◽  
Calvin Pan ◽  
...  

2021 ◽  
Vol 5 (Supplement_1) ◽  
pp. A769-A770
Author(s):  
Valentina Rodriguez Paris ◽  
Stephanie J Alexopoulos ◽  
Ying Hu ◽  
Divya P Shah ◽  
Ali Aflatounian ◽  
...  

Abstract Polycystic ovary syndrome (PCOS) is a prevalent endocrine condition characterized by endocrine, reproductive and metabolic dysfunction. At present, there is no cure for PCOS and current treatments are suboptimal. Obesity and adverse metabolic features are prevalent in women with PCOS, with weight loss having a beneficial effect on PCOS features. The use of dietary interventions aimed at weight loss have low long-term compliance in women suffering from PCOS. Recent data from animal studies has shown that a small molecule mitochondrial uncoupler, BAM15, is an effective method to pharmacologically treat obesity and metabolic diseases. Therefore, the aim of this study was to investigate the efficacy of BAM15 to ameliorate PCOS-traits in a hyperandrogenic PCOS mouse model. As expected, exposure of female mice to dihydrotestosterone (DHT) induced the PCOS metabolic features of increased body weight (P<0.05), lean mass (P<0.001), increased parametrial and mesenteric fat pad weights (both P<0.05) and adipocyte hypertrophy (P<0.05). Additionally, DHT-induced PCOS mice exhibited insulin resistance measured by HOMA-IR, increased cholesterol and fasting triglyceride levels and hepatic steatosis (all P<0.05). In contrast, DHT-induced PCOS females treated with BAM15 displayed body weights which were comparable with controls, a significant decrease in parametrial and mesenteric fat depot weights (P<0.05) and reduced adipocyte hypertrophy. Furthermore, BAM15 treatment decreased insulin resistance, cholesterol and fasting triglyceride levels, as well as the degree of hepatic steatosis observed in PCOS females, to levels comparable with controls. PCOS mice presented the reproductive PCOS traits of irregular cycles and ovulatory dysfunction, however BAM15 did not improve these PCOS traits. These findings demonstrate that the pharmacologic mitochondrial uncoupler BAM15 is able to ameliorate metabolic PCOS features in a hyperandrogenic PCOS mouse model. These data provide compelling evidence to support BAM15 as a potential innovative and viable therapeutic approach to manage metabolic traits associated with PCOS.


Sign in / Sign up

Export Citation Format

Share Document